S&P 500 and Nasdaq 100 Rally to Record Highs on a Resilient US Economy

US equities rallied to new record highs on Thursday, with the S&P 500 and Nasdaq 100 leading gains, propelled by stronger-than-expected economic data—including falling jobless claims and robust retail sales—alongside dovish remarks from San Francisco Fed President Mary Daly hinting at two rate cuts this year. However, market sentiment was complicated by escalating tariff uncertainty, as President Trump announced new tariffs on EU, Mexico, and Canada, while health insurers notably declined following Elevance Health's reduced earnings outlook. Treasury yields also rose on the strong economic indicators and mixed Fed commentary, reflecting a complex interplay of economic strength, monetary policy expectations, and trade tensions.

Analysis

US equity indices, including the S&P 500 and Nasdaq 100, reached new record highs, propelled by a confluence of strong domestic economic data and dovish commentary from a Federal Reserve official. Robust economic indicators, such as weekly jobless claims falling to a 3-month low of 221,000 and June retail sales rising +0.6% month-over-month, significantly exceeded expectations and signaled underlying economic resilience. This sentiment was further bolstered by San Francisco Fed President Daly's remarks suggesting two 25 bp rate cuts by year-end. However, this optimism is juxtaposed with significant headwinds and conflicting signals. Hawkish comments from Fed Governor Kugler, who advocated for holding rates "for some time," and a rise in the 10-year T-note yield to 4.463% reflect persistent inflation concerns. Moreover, escalating trade tensions present a material risk, with the administration announcing new tariffs on the EU, Mexico, and Canada, while simultaneously suggesting a potential easing of chip export restrictions to China. The corporate earnings landscape is also mixed; while companies like PepsiCo (+7%) and Travelers (+3%) reported strong results, the health insurance sector faced a sharp sell-off, led by Elevance Health's -12% plunge after a significant cut to its earnings outlook, and the consensus forecast for S&P 500 Q2 earnings growth is a modest +2.8% y/y, the slowest in two years.

Key Decisions for Investors

• Despite record highs, investors should remain cautious due to the significant divergence between strong economic data and escalating, multi-front trade tariff risks which could rapidly alter market sentiment.
• Focus on sector-specific and stock-level analysis, as evidenced by the sharp contrast between outperforming consumer staples like PepsiCo and underperforming health insurers like Elevance Health, which highlights a market driven by individual fundamentals rather than broad beta.
• Monitor upcoming US-China trade negotiations and Fed communications closely, as any signs of easing trade tensions could favor chipmakers, while a hawkish shift from the FOMC could challenge the current equity rally.
• Consider the weakness in the health insurance sector as a potential area for short positions or underweighting, given the significant guidance cut from Elevance Health (ELV) has triggered broad-based selling across peers like Molina (MOH) and Centene (CNC).